Does insurance cover Wegovy?
A plain-English look at when Wegovy tends to be covered in 2026 — so you know where you stand before you spend.
See your personalized coverage estimate →The short answer
Whether insurance covers Wegovy depends heavily on why it is prescribed. Wegovy (semaglutide) is approved for weight loss and to reduce cardiovascular risk. Coverage for the cardiovascular indication is generally stronger, while coverage for weight loss alone is the harder, more variable case. This page is educational information about coverage likelihood, not medical advice or a guarantee — your plan and clinician make the final call.
Coverage by insurance type
Commercial employer plans: roughly 45% of large employers cover an anti-obesity medication in 2026 (up from about 25% in 2023), but this drops with company size — around 43% of firms with 5,000+ employees, about 30% mid-size, and roughly 16% of small firms. Prior authorization is nearly universal. Medicare: weight loss alone is excluded by law, but the cardiovascular indication for Wegovy is covered under Part D, and a new Medicare GLP-1 Bridge (2026-2027) covers Wegovy at $50/month with attestation and BMI criteria. Medicaid: diabetes is covered in all 50 states; obesity coverage exists in about 13 states as of January 2026. ACA Marketplace: anti-obesity meds are not an Essential Health Benefit, so weight-loss coverage is rare (about 9% of carriers, 1% of plans). TRICARE: Wegovy for weight loss is limited to Prime/Select family members with prior authorization and documentation. (Sources: KFF, Medicare.gov/CMS, tricare.mil, as of 2026-07.)
Why prior authorization matters
Even when a plan lists Wegovy, prior authorization is nearly universal for weight-loss coverage. Plans commonly ask for a documented BMI threshold and a history of diet-and-exercise efforts before approving. Gathering those records up front — your BMI, past weight-management attempts, and relevant health conditions — is often what makes the difference between an approval and a denial.
How Body Good can help
Body Good is a helpful next step, not a cure or a coverage guarantee. Our coverage checker asks a few questions about your insurance and situation, then gives you a personalized estimate of how likely Wegovy is to be covered and what documentation your plan tends to want. From there, you and a licensed clinician can decide what makes sense for you.
Check your coverage in ~2 minutes
Frequently asked questions
Is Wegovy covered for weight loss?
Sometimes. About 45% of large employers cover an anti-obesity medication in 2026, but coverage varies by employer size and is rare on ACA Marketplace plans (roughly 9% of carriers). Medicare excludes weight-loss-only use by law. Prior authorization is nearly always required.
Does Medicare cover Wegovy?
Medicare covers Wegovy for its cardiovascular (heart-risk) indication under Part D, and the Medicare GLP-1 Bridge (2026-2027) covers Wegovy at $50/month with provider attestation and BMI criteria. Weight loss alone is excluded by law.
Why do I need prior authorization for Wegovy?
Most plans require prior authorization to confirm you meet their criteria, which often include a BMI threshold and documented diet-and-exercise history. It is a paperwork step, not an automatic denial.
What if my plan does not cover Wegovy?
You still have options, which may include appealing with documentation, checking the Medicare GLP-1 Bridge if eligible, or discussing alternatives with your clinician. A coverage checker can show you which paths fit your situation.
Sources · as of 2026-07
- KFF — Employer Health Benefits Survey (anti-obesity coverage by employer size)
- KFF — ACA Marketplace GLP-1 coverage analysis
- Medicare.gov / CMS — Part D and GLP-1 Bridge fact sheet
- tricare.mil — weight-loss medication coverage